大麻使用,认知功能和老年人痴呆风险:观察和遗传分析
Saba Ishrat1, Daniel F Levey2,3, Joel Gelernter2,3
1Department of Psychiatry, University of Oxford, Oxford, UK.
BMJ mental health
|February 25, 2026
概括
老年人使用大麻与认知能力下降或痴呆风险无关. 这些发现表明,大麻可能不会在这个人群中显著影响认知衰老.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大麻对老年人的认知影响尚不清楚.
- 在这个人口群体中增加大麻使用需要研究.
研究的目的:
- 调查大麻使用,认知表现和老年人痴呆风险之间的关联.
- 使用孟德尔随机化 (MR) 探索潜在的因果关系.
主要方法:
- 使用英国生物银行和百万退伍军人计划队伍的观察分析.
- 横截面和纵向认知评估.
- 用于因果推断的MR分析.
主要成果:
- 大麻使用者在数值记忆和流体智力方面表现出适度的基线改善.
- 在纵向认知变化中没有观察到显著差异.
- 大麻使用障碍与痴呆风险没有显著关联;MR没有提供因果关系的证据.
结论:
- 老年人使用大麻与加速认知衰退或痴呆症风险增加无关.
- 目前的证据不支持大麻使用对认知衰老或痴呆症的重大贡献.
- 建议进行进一步的研究,进行详细的暴露评估和更长的随访.
更多相关视频
相关概念视频
Dementia
609
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
609
Pharmacodynamics in Geriatric Patients: Effects of Age
284
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
284
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
735
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
735
Drug Dosing: Geriatric Patients
327
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
327
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988


